Abstract
Traditional Chinese medicine (TCM) is gaining popularity as a form of complementary and alternative medicine. Reports of efficacy of TCM are increasing in numbers. TCM includes both crude Chinese medicinal materials (plants, animal parts and minerals) and Chinese proprietary medicine (CPM) [final dosage forms]. Despite the belief that CPM and herbal remedies are of natural origin, unlike Western medicine, and are hence safe and without many adverse effects, there have been numerous reports of adverse effects associated with herbal remedies. Factors affecting the safety of herbal medicines include intrinsic toxicity, adulteration, substitution, contamination, misidentification, lack of standardisation, incorrect preparation and/or dosage and inappropriate labelling and/or advertising. Hence, new regulations on the control of CPM were enforced in Singapore with effect from 1 September 1999. These include licensing and labelling requirements, as well as control of microbial contamination. This article also reviews reports of excessive toxic heavy metals and undeclared drugs in CPM in Singapore between 1990 and 1997. The names, uses, toxic heavy metal or drug detected and the year of detection are tabulated. Information on the brand or manufacturer’s name are provided whenever available. The public and healthcare professionals should be better informed of the basic concept of TCM and its usefulness, as well as the potential adverse effects associated with its use. Greater control over the safety and quality of CPM could be achieved through good manufacturing practice, regulatory control, research, education, reporting usage of Chinese medicine (as in drug history) as well as reporting of adverse events.
Similar content being viewed by others
References
Anonymous. Program profile: international liaison brings global vision to OAM. Complementary and Alternative Medicine at the NIH 1996; 3:3
Eisenberg DM, Ronald CK, Forster C, et al. Unconventional medicine in the United States: prevalence, costs, and patterns of use. N Engl J Med 1993; 328: 246–52
MacLennan AH, Wilson DH, Taylor AW. Prevalence and cost of alternative medicine in Australia. Lancet 1996; 347: 569–72
Zhu YP. Chinese materia medica: chemistry, pharmacology and applications. Amsterdam: Harwood Academic Publishers, 1998
Fok TF, Lau SP, Hui CW. Chinese herbs in pregnancy and neonatal jaundice. Hong Kong J Paediatr 1985; 2: 138–44
Chan YK. The prevalence, use and harmful potential of some chinese herbal medicines in babies and children. Vet Hum Toxicol 1994; 36 (3): 238–40
Traditional Chinese medicine: a report by the Committee on Traditional Chinese Medicine. Singapore: Ministry of Health, 1995
Huxtable RJ. The harmful potential of herbal and other plant products. Drug Saf 1990; 5 Suppl. 1: 126–36
Drew AK, Myers SP. Safety issues in herbal medicine: implications for the health professions. Med J Aust 1997; 166 (19): 538–41
Chan YK, Critchley JAJH. Usage and adverse effects of Chinese herbal medicines. Hum Exp Toxicol 1996; 15: 5–12
Dickens P, Tai YT, But PPH, et al. Fatal accidental aconitine poisoning following ingestion of Chinese herbal medicine: a report of 2 cases. Forensic Sci Int 1994; 67: 55–8
Vanherweghem JL, Depierreux M, Tielemans C et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993; 341: 387–91
Vanhaelen M, Vanhaelen-Fastre R, But P, et al. Identification of aristolochic acid in Chinese herbs [letter]. Lancet 1994; 343: 174
Shaw D, Murray V, Volans G. Adverse effects of herbal remedies and OTC medicines. Br J Clin Pharmacol 1999; 47 (2): 227–8
Shaw D, Leon C, Kolev S, et al. Traditional remedies and food supplements: a 5-year toxicological study 1991-1995. Drug Saf 1997; 17 (5): 342–56
De Smet PAGM. Overview of herbal quality control. Drug Inf J 1999; 33: 717–24
De Smet PAGM. Health risks of herbal remedies. Drug Saf 1995; 13 (2): 81–93
De Smet PAGM, editor. Adverse effects of herbal drugs. Vol. I. Berlin: Springer Verlag, 1992
De Smet PAGM, editor. Adverse effects of herbal drugs. Vol II. Berlin: Springer Verlag, 1993
De Smet PAGM, editor. Adverse effects of herbal drugs. Vol III. Berlin: Springer Verlag, 1997
Forster S, Tyler VE. Tyler’s honest herbal: a sensible guide to the use of herbs and related remedies. 4th ed. New York (NY): Haworth Press, 1999
Newall CA, Anderson LA, Phillipson JD. Herbal remedies: a guide for healthcare professionals. London: The Pharmaceutical Press, 1996
The Chinese Pharmacopoeia Commission of the Ministry of Public Health. Pharmacopoeia of the People’s Republic of China, 1995 edition. Vol. 1. Guangdong: Guangdong Technology Publisher and Chemical Industries Publisher, 1995
Hikino H, Yamada C, Nakamura K, et al. Change of alkaloid composition and acute toxicity of Aconitum roots during processing. Yakugaku Zasshi 1977; 97: 359–66
Du S, Cao F, Lei S. A survey of adverse effects of Chinese herbal drugs in China, 1915-1990. Chung Kuo Chung Yao Tsa Chih 1992; 17: 435–8
Yuan H, Tan D. A review of the literature of the adverse effects of Chinese herbal drugs as published in major medical and pharmacology journals in China in 1990. Chung Kuo Chung Yao Tsa Chih 1991; 16: 628–34
The statutes of the Republic of Singapore: medicines act (chapter 176), revised edition 1990. Singapore: The Government Printer, Ministry of Health
Jiang Su Xin Yi Xue Yuan. Zhong Yao Da Ci Dian (A dictionary of Chinese pharmacy). Shanghai: Shang Hai Ke Xue Ji Shu ChuBan She, 1977
Li Shi Zhen (1518-1593). Ben Cao Gang Mu (The Chinese herbal medicine materia medica). 1596
The statutes of the Republic of Singapore: poisons act (chapter 234), revised edition 1999. Singapore: The Government Printer, Ministry of Health
The statutes of the Republic of Singapore: medicines (advertisement and sale) act (chapter 177), revised edition 1985. Singapore: The Government Printer, Ministry of Health
The statutes of the Republic of Singapore: sale of drugs act (chapter 282), revised edition 1985. Singapore: The Government Printer, Ministry of Health
Ennever FK. Metals. In: Hayes WA, editor. Principles and methods of toxicology. 3rd ed. New York (NY): Raven Press, 1994: 417–46
Olson KR, editor. Poisoning and drug overdose. 3rd ed. Stanford (CT): Appleton & Lange, 1999
Dukes MNG, editor. Meyler’s side effects of drugs: an encyclopedia of adverse reactions and interactions. 13th ed. Amsterdam: Elsevier Science, 1996
Klaassen CD, Amdur MO, Doull J, editors. Casarett and Doull’s toxicology: the basic science of poisons. 5th ed. New York (NY): McGraw-Hill, 1996
Kang YE, Oransky SH. Chinese patent medicine as a potential source of mercury poisoning. Vet Hum Toxicol 1992; 34 (3): 235–8
Tay CH, Seah CS. Arsenic poisoning from anti-asthmatic herbal preparations. Med J Aust 1975; 2: 424–8
Yeung HC. Handbook of Chinese herbs and formulas. Vol. II. Los Angeles (CA): Institute of Chinese Medicine, 1985
Yu ECL, Yeung CY. Lead encephalopathy due to herbal medicine. Chin Med J 1987; 100: 915
Chia BL, Leng CK, Hsii FP, et al. Lead poisoning from contaminated opium. BMJ 1973; 1: 354
Schilcher H. Contamination of natural products with pesticides and heavy metals. In: Breimer DD, Speiser P, editors. Topics in pharmaceutical sciences. Amsterdam: Elsevier Science, 1983: 417–23
Woolf GM, Petrovic LM, Rojter SE, et al. Acute hepatitis associated with the Chinese herbal product Jin Bu Huan. Ann Intern Med 1994; 121 (10): 729–35
Ministry warning on Jin Bu Huan pills. The Straits Times. Singapore: Singapore Press Holdings: 8 Mar 1995
Tung Shueh Wan herbal product has poinonous substances; Health Ministry. The Straits Times. Singapore: Singapore Press Holdings: 1 Nov 1992
Abt AB, Oh JY, Huntingdon RA, et al. Chinese herbal medicine induced acute renal failure. Arch Intern Med 1995; 155 (2): 211–2
Illegal sale of medicinal [press release]. Singapore: Ministry of Health, 1997 Nov
Tang W, Eisenbrand G. Chinese drugs of plant origin. Berlin: Springer Verlag, 1992
Yeung CY, Lee FT, Wong HN. Effects of a popular Chinese herb on neonatal bilirubin protein binding. Biol Neonate 1990; 58: 98–103
International Agranulocytosis and Aplastic Anemia Study. Risks of agranulocytosis and aplastic anemia: a first report of their relation to drug use with special reference to analgesics. JAMA 1986; 256: 1749
Two die after taking ‘wonder’ pills for diabetes: made-in-China drug has been banned in Singapore since 1977. The Straits Times. Singapore: Singapore Press Holdings: 24 Jul 1990
Huang WF, Wen KC, Hsiao ML. Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan. J Clin Pharmacol 1997; 37: 344–50
Liu SY, Woo SO, Holmes MJ, et al. LC and LC-MS-MS analyses of undeclared codeine in antiasthmatic Chinese proprietary medicine. J Pharm Biomed Anal 2000; 22 (3): 481–6
Ko RJ. Causes, epidemiology and clinical evaluation of suspected herbal poisoning. Clin Toxicol 1999; 37 (6): 697–708
Tomlinson B, Chan TY, Chan JC, et al. Toxicity of complementary therapies; an eastern perspective. J Clin Pharmacol 2000; 40 (5): 451–6
Boullata JI, Nace AM. Safety issues with herbal medicine. Pharmacotherapy 2000; 20 (3): 257–69
Marrone CM. Safety issues with herbal products. Ann Pharmacother 1999; 33 (12): 1359–69
Miller LG, Hume A, Harris IM, et al. White paper on herbal products. Pharmacotherapy 2000; 20 (7): 877–91
Acknowledgments
This work is supported by an academic research fund (RP3972353) from the National University of Singapore. The support of the Department of Scientific Services of the Institute of Science and Forensic Medicine is acknowledged. The assistance of the National Pharmaceutical Administration of the Ministry of Health, Singapore in providing some of the data is greatly appreciated. The authors are indebted to the reviewers for their constructive and useful comments.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Koh, HL., Woo, SO. Chinese Proprietary Medicine in Singapore. Drug-Safety 23, 351–362 (2000). https://doi.org/10.2165/00002018-200023050-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-200023050-00001